The integration of morphofunctional assessment, including body composition at the T12 level, functional performance tests, and mitochondrial biomarkers such as GDF-15 and PGC-1α, enabled a more accurate classification of cachexia phenotypes. This evidence concerns the gene GDF15 and Cachexia.